To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
The design of bathrooms has evolved considerably over the years, reflecting changes in fixtures, materials, aesthetics, spatial preferences, and development. One notable trend is the rise of the ...
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...
The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...
Pharmaceutical company Moderna has been granted the funds to work on developing mRNA-based influenza vaccines, including for the strain causing the bird flu outbreak. Newsweek has contacted ...
Moderna Inc (NASDAQ:MRNA) stock is surging today, up 8.7% at $37.02 at last glance, after the vaccine maker was awarded $590 million from the U.S. Health and Human Services Department to speed up ...
The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can ...
Use the live Pfizer Inc BDR share price chart to monitor the movements of the stock in real-time. Assess key data such as the daily change, high and low prices. A handy PFIZ34 trading volume graph is ...